Study of Antibody Localization in Colorectal Cancer
Author Information
Author(s): M.R. Price, M.V. Pimm, C.M. Page, N.C. Armitage, J.D. Hardcastle, R.W. Baldwin
Primary Institution: Cancer Research Campaign Laboratories, University of Nottingham
Hypothesis
The localization of the 791T/36 monoclonal antibody in colorectal carcinomas is driven by an immune mechanism.
Conclusion
The study found that the 791T/36 antibody localizes within colorectal tumors due to immune recognition of a specific target antigen.
Supporting Evidence
- The antibody predominantly localizes in stromal elements and secretions within pseudoacini rather than malignant cells.
- Three patients were studied, showing varying tumor to normal tissue ratios.
- Major localization of the antibody was found in fibrous material from the tumor.
Takeaway
Doctors used a special antibody to see where it goes in cancer tumors, and they found it mostly sticks to the tumor because it recognizes something special there.
Methodology
Patients were injected with 131I-labelled 791T/36 monoclonal antibody, and tumor and normal tissue samples were analyzed for radioactivity.
Participant Demographics
Patients had colorectal adenocarcinomas of varying stages and differentiation.
Want to read the original?
Access the complete publication on the publisher's website